Prevalence, incidence, and mortality rates of breast cancer in Kazakhstan: data from the Unified National Electronic Health System, 2014–2019

Midlenko A. Mussina K. Zhakhina G. Sakko Y. Rashidova G. Saktashev B. Adilbay D. Shatkovskaya O. Gaipov A.
2023 Frontiers Media S.A.

Frontiers in Public Health
2023 #11

Background: Although there are numerous sources of epidemiologic information on breast cancer in Kazakhstan, none of them have specifically examined the burden of this disease. Therefore, this article aims to provide an overview of the breast cancer prevalence, incidence, mortality, and distribution and changes over time in Kazakhstan based on nationwide large-scale healthcare data from the National Registry in order to encourage more research on the impact of various diseases at the regional and national levels. Methods: The study cohort included all adult women older than 25 years who were diagnosed with breast cancer in any clinical setting of the Republic of Kazakhstan during the period of 2014–2019. The data were extracted from the Unified Nationwide Electronic Health System (UNEHS) to get an overview of descriptive statistics, incidence, prevalence, and mortality rate calculations and the Cox proportional hazards regression model. All survival functions and factors associated with mortality were tested for significance. Results: The cohort population (n = 55,465) comprised subjects with the age at the diagnosis of breast cancer from 25 to 97 years, with a mean of 55.7 ± 12.0 years. The majority of the study population belonged to the age group 45–59 years, which is 44.8% of the cohort. The all-cause mortality rate of the cohort is 16%. The prevalence rate increased from 30.4 per 10,000 population in 2014 to 50.6 in 2019. The incidence rate varied from 4.5 per 10,000 population in 2015 to 7.3 in 2016. Mortality rates were stable and high in the senile age patients (75–89 years old). Breast cancer mortality was positively associated with women who had been diagnosed with diabetes, HR 1.2 (95% CI, 1.1–2.3), whereas it was negatively associated with arterial hypertension, HR 0.4 (95% CI, 0.4–0.5). Conclusion: Overall, Kazakhstan is experiencing an increase in the incidence of breast cancer cases, but the mortality rate has started to decline. The switch to population mammography screening could reduce the breast cancer mortality rate. These findings should be utilized to help Kazakhstan determine what cancer control priorities should be utilized, including the need to implement efficient and affordable screening and prevention programs. Copyright

breast cancer , incidence , Kazakhstan , Kazakhstan breast cancer , mortality , prevalence

Text of the article Перейти на текст статьи

Department of Surgery, School of Medicine, Nazarbayev University, Astana, Kazakhstan
Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan
School of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan
Department of Mammology, Oncological Center of Tomotherapy “UMIT”, Astana, Kazakhstan
Department of Otolaryngology Head and Neck Surgery, Louisiana State University Health Sciences, Shreveport, LA, United States
Department of Scientific and Strategic Activities, Kazakh Research Institute of Oncology and Radiology, Almaty, Kazakhstan
Clinical Academic Department of Internal Medicine, CF “University Medical Center”, Astana, Kazakhstan

Department of Surgery
Department of Medicine
School of Sciences and Humanities
Department of Mammology
Department of Otolaryngology Head and Neck Surgery
Department of Scientific and Strategic Activities
Clinical Academic Department of Internal Medicine

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026